BioKier is a pharmaceutical company with a focus on developing innovative treatments for diabetes and related metabolic health issues. Founded in 2008 and based in Chapel Hill, North Carolina, the company specializes in oral medications targeting type 2 diabetes, metabolic syndrome, and obesity. BioKier received a $150.00K Venture Round investment on 01 January 2015. With its pioneering approach and commitment to addressing critical health concerns, BioKier is positioned as a significant player in the biotechnology and pharmaceutical industries, offering promising opportunities for potential investors and strategic collaborators.
BioKier, Inc.
Pioneering Solutions for Diabetes and Metabolic Health Since 2008
Founded 2008
Chapel Hill, United States
5 employees
Venture round
Total: $2.89M
Biotechnology, Pharmaceutical
Chapel Hill, United States
5 employees
Venture round
Total: $2.89M
Biotechnology, Pharmaceutical
General Information
Company Name
BioKier, Inc.
Founded Year
2008
Location
Chapel Hill, United States
Chapel Hill, United States
Employees
5
Industries
Biotechnology, Pharmaceutical
Funding Stage
Venture round
BounceWatch is an independent company data service, not affiliated with BioKier, Inc.. To contact BioKier, Inc., visit biokier.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does BioKier, Inc. compare?
A PDF of BioKier, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting BioKier, Inc. soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
United States Market
Biotechnology
About BioKier, Inc.
Business keywords: pharmaceutical company, diabetes treatment, metabolic health, oral medications, type 2 diabetes, metabolic syndrome, obesity, early-stage company, drug development, Chapel Hill, North Carolina
Funding Rounds & Investors (7)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | $150.00K | - |
|
01 Jan 2015 |
| Debt Financing | $230.00K | - |
|
04 Aug 2014 |
| Angel Round | $230.00K | - |
|
01 Jan 2014 |
| Seed Round | $1.70M | 2 |
|
24 Jul 2013 |
| Seed Round | $40.00K | - |
|
14 May 2013 |
| Venture Round | $340.00K | - |
|
31 Aug 2011 |
| Seed Round | $200.00K | - |
|
07 Aug 2009 |
BioKier, Inc. Alternatives & Competitors
View All Alternatives
BioKier, Inc. vs
Pioneering innovative therapies to enhance the lives of patients with metabolic and fibrotic conditi...
Series C
Biopharma, Biotechnology
BioKier, Inc. vs
Pioneering the future of metabolic disease treatment by harnessing genetic interactions to combat ag...
Series D
Biotechnology, Pharmaceutical
BioKier, Inc. vs
Pioneering the path towards disease-modifying solutions for type 2 diabetes
Venture round
11-50 employees
Biotechnology, Health Care
FAQ About BioKier, Inc.
Pioneering Solutions for Diabetes and Metabolic Health Since 2008
BioKier, Inc. was founded in 2008.
BioKier, Inc. is headquartered in Chapel Hill, United States.
BioKier, Inc. operates in Biotechnology and Pharmaceutical. Its work centres on pharmaceutical company, diabetes treatment, metabolic health and oral medications.
BioKier, Inc. has approximately 5 employees.
BioKier, Inc. has completed 7 funding rounds, raising a total of $2.89M. The latest funding stage is Venture round.
Top alternatives and competitors to BioKier, Inc. include Inversago Pharma, Elixir Pharmaceuticals, Genmedica Therapeutics, Glyscend Therapeutics, Galleon Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BioKier, Inc. and Inversago Pharma are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for BioKier, Inc., https://bouncewatch.com/company/biokier, updated 14 January 2025. When citing, please name BounceWatch and link this page.
